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Abstract
Background: Domestic violence and abuse remains a major health concern. It is unknown whether the improved
healthcare response to domestic violence and abuse demonstrated in a cluster randomised controlled trial of IRIS
(Identification and Referral to Improve Safety), a complex intervention, including general practice based training,
support and referral programme, can be achieved outside a trial setting. Aim: To evaluate the impact over four
years of a system wide implementation of IRIS, sequentially into multiple areas, outside the setting of a trial.
Methods: An interrupted time series analysis of referrals received by domestic violence and abuse workers from
201 general practices, in five northeast London boroughs; alongside a mixed methods process evaluation and
qualitative analysis. Segmented regression interrupted time series analysis to estimate impact of the IRIS
intervention over a 53-month period. A secondary analysis compares the segmented regression analysis in each of
the four implementation boroughs, with a fifth comparator borough.
Discussion: This is the first interrupted time series analysis of an intervention to improve the health care response
to domestic violence. The findings will characterise the impact of IRIS implementation outside a trial setting and its
suitability for national implementation in the United Kingdom.
Keywords: Domestic violence abuse complex intervention implementation evaluation
Background
This paper reports the protocol for a system wide
implementation evaluation of IRIS - Identification and
Referral to Improve Safety of women affected by do-
mestic violence and abuse (DVA), a complex interven-
tion, designed to improve the primary healthcare
response to DVA.
According to World Health Organization (WHO) and
National Institute for Health and Care Excellence
(NICE) guidelines, health professionals should be trained
to provide assistance for women affected by DVA by
facilitating disclosure, checking their safety, offering sup-
port and referral, and providing the appropriate medical
services and follow-up care [1, 2]. These guideline
recommendations are based on research from multiple
health settings. This research includes how to effectively
identify those affected by DVA and record DVA safely,
in emergency care [3], antenatal [4], maternity & sexual
health services [5], HIV clinics [6], community gynaecology
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[7], mental health [8] and primary care [9]. Yet globally, cli-
nicians often do not respond adequately to DVA [10]. In
primary care, effective clinical management of common
conditions (such as depression or unexplained pain) is not
possible if a patient’s experience of abuse remains hidden
[11]. IRIS is an evidence based innovative model of care
that addresses this gap in healthcare provision and the
suboptimal response to DVA in primary care [9].
The IRIS pragmatic cluster randomised controlled trial
in 24 intervention and 24 control general practices, in two
English cities, showed a three-fold difference in identifica-
tion of women affected by DVA and a seven-fold differ-
ence in referral to specialist DVA services between control
and IRIS practices respectively [9]. This was the first evi-
dence that a system level intervention could improve the
healthcare response to DVA, by increasing the referrals
made of women affected by abuse, to an IRIS advocacy
worker (the advocate-educator). A Cochrane review shows
that brief advocacy may reduce abuse, improve mental
health and quality of life, especially for less severe abuse
and in pregnant women [12]. IRIS with its focus on offer-
ing women referral for specialist DVA advocacy was also
estimated to be cost-effective [13]. Qualitative analysis
nested within the original IRIS trial showed that women
were positive about being asked about abuse by health
professionals and contact with DVA advocates [14].
Health professionals viewed IRIS as an acceptable inter-
vention but had a concern about the four hours’ length of
training [15]. Trial results showed a wide variation in
DVA identification and referral rates between IRIS prac-
tices and amongst clinicians within IRIS practices [9].
Based on the original trial, the IRIS model has been in-
cluded as an example of best practice in multiple policy
and guidance documents, including by NICE [2], the
WHO [1], the UK government [16], the Chief Medical
Officer [17] and the Home Office [18].
DVA’s health effects are more burdensome than hyper-
tension, obesity, high cholesterol and smoking in women
of reproductive age [19]. DVA is the top contributor to
death, disability and illness in these women [20]; its man-
agement in clinical practice warrants much greater atten-
tion. Gynaecological and sexual health problems are the
most prevalent and persistent physical health consequence
of DVA [21]. Long-lasting mental health problems include
depression, anxiety and post-traumatic stress disorder -
the most prevalent mental health sequelae [22].
In the UK, since the recession of 2008/09, violent
crime against women has increased [23]. Yet between
2008 and 2013, funding for specialist support services’
has decreased by a third [24], despite DVA costing an
estimated £11 billion in lost economic output, social
services, emotional and medical costs in 2012 [25].
The IRIS programme was developed as a primary
health care contribution to a societal response to DVA,
linking general practice to DVA services. The training,
support and referral pathway is a complex intervention
that enables clinicians to ask about DVA, recognise the
DVA in a woman’s life, understand and be able to dis-
cuss with her that abuse’s significance to her health
whilst providing excellent clinical care, taking the abuse
into account and offering a referral to a named specialist
within a DVA support service.
Despite the trial evidence, the national policy documents
supporting IRIS, and the initial commissioning of IRIS in
34 areas, we do not know whether the programme is sus-
tainable and effective when implemented outside the trial
context. We need to determine whether IRIS and its
original trial results can be replicated in general practice
settings over the longer term. The UK Medical Research
Council advises “…effects are likely to be smaller and more
variable once the intervention becomes implemented more
widely, and…long-term follow-up may be needed to
determine whether short-term changes persist” [26].
Methods
Primary objective
1. To measure the effectiveness of IRIS alongside a
comparator intervention, in general practice, both
designed to improve the healthcare response to
DVA in primary care.
Secondary objectives
2. To understand the process of IRIS implementation,
using a mixed methods approach, including survey
and qualitative data.
3. To evaluate IRIS implementation, alongside IRIS’
sustainability, with in depth case studies of two
different IRIS areas using interviews, participant
observation and document analysis.
Design
A four year observational, pragmatic, mixed methods,
implementation MRC phase IV study [27]:
The principal design is a segmented regression analysis
of interrupted time series (ITS) data (primarily, referrals
received by DVA workers) from general practices that
implemented the IRIS intervention and a comparator
borough in which the general practices did not imple-
ment the IRIS intervention.
There are approximately 386,277 women, aged 16 years
and above (patients), registered at the 140 general practices,
in the four north-east London implementation borough
sites (A, B, C & D), for which IRIS was commissioned; and
approximately 77,464 women aged 16 years and above
(patients), registered at the 61 general practices, in an adja-
cent comparator north-east London borough site (E). The
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comparator borough has not implemented the studied
intervention (IRIS) but instead used an alternative DVA ini-
tiative, during the time period examined.
Qualitative research is carried out in parallel, including
a concurrent embedded, mixed-method process evalu-
ation of IRIS implementation and two in-depth, local,
IRIS case studies with a sustainability focus.
All results are integrated, by considering the quantita-
tive and the qualitative results alongside each other,
checking that results coincide (for example, are areas
with the highest incidence rate ratios for referrals re-
ceived also the areas in which IRIS has the greatest
training reach) whilst reflecting on discordant results, in
order to increase understanding about IRIS implementa-
tion, sustainability and effectiveness.
Setting
This implementation evaluation involves eight sites. Four
of these are northeast London borough implementation
sites (A, B, C & D) that commissioned IRIS within the
study period. One is a comparator northeast London
borough site (E) that did not commission IRIS but an al-
ternative DVA initiative. One is an original IRIS trial inter-
vention borough (F) that commissioned IRIS after the
original trial. Additionally, an urban northern IRIS area
(G) had an IRIS service started within the study period.
The personnel involved included all staff at each general
practice (clinical and administrative), DVA service pro-
viders’ staff and commissioners, including NHS clinical
commissioning group staff (clinical leads for child/adult
safeguarding and women’s health) and local council staff
(concerned with local DVA strategy and public health).
Population/ participants
Sites are invited to take part in this research due to their
geographical location in the North Thames area of London,
adjoining the original IRIS intervention trial site with a
priori knowledge that areas are interested in IRIS commis-
sioning. One IRIS site outside of London is included as a
qualitative case study, as it fulfilled pre-specified inclusion
criteria of this work (see Appendix A). IRIS targets women
affected by DVA, either currently or historically, from a
partner, ex-partner or an adult family member. The eligibil-
ity criteria to be included in this observational study are:
female patients aged 16 and above, registered at a general
practice, at the sites being studied. Women affected by
DVA are identified by a clinician and offered a referral to
the named IRIS advocate-educator (AE); or women can
self-refer to IRIS if they see the publicity material displayed
within a surgery.
Intervention
IRIS is a general practice-based DVA training, support
and referral programme for primary care staff. The
theoretical framework of the training is based on educa-
tional outreach, adult learning theory and peer influence.
It was developed using the MRC framework for complex
interventions, to improve the primary care response to
DVA. This involved steps for development, piloting and
testing the intervention in a trial design followed by im-
plementation in routine general practice [26].
The IRIS model consists of five core components:
1. Practice based DVA training, with two two-hour
sessions for the whole practice team.
2. A local GP, interested in DVA, appointed as an IRIS
clinical lead (CL) delivers clinical training alongside
an IRIS AE.
3. A named DVA specialist – an IRIS AE - employed
and based in a local DVA service, delivers training
and also receives referrals from clinicians,
responsible for a caseload of work, providing on-
going support, refresher training and consultancy
for the entire practice team, on a day to day basis
when in the practice (preferably attending regular
quarterly practice meetings), by phone and email.
4. The AE sees women affected by DVA, providing
expert advocacy, including risk assessments, safety
planning, emotional & mental health support, housing
advice, referring, (e.g. to multi-agency risk assessment
conferences (MARACs), child safeguarding services),
support on injunctions & criminal justice system,
signposting (e.g. to specialist DVA legal services) and
accompanying to police or courts.
5. An electronic prompt, reminds clinicians to ask
about DVA, considering its multiple dimensions
[28] and a template within which to record DVA
(encouraging clinicians to (i) assess the immediate
safety of the woman and any children, (ii) offer
referral, (iii) review within general practice). The
electronic prompt is triggered by codes for health
conditions or symptoms associated with DVA, such
as fatigue, insomnia, anxiety and depression.
The AE is an experienced specialist support DVA
worker, with previous training experience. The CL is
interested in DVA as a health issue, preferably also with
training experience. Both the IRIS AEs and CLs have com-
pleted the national IRIS Training for Trainers programme,
delivered by IRISi staff,1 over three and two days respect-
ively. The IRIS model is based on one full-time AE work-
ing with 25 general practices. The model is built upon
partnership work, with primary care and specialist third
sector agencies coming together to deliver services and
promote work across the interdisciplinary gap. Further
details about training (e.g. flowcharts showing simple
referral pathways and various IRIS publicity materials to
display in practices) are given in Additional file 1.
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Comparator intervention
The alternative DVA intervention delivered in the com-
parator site, E, also comprised a DVA education package.
This involved training delivered away from general prac-
tices, training was delivered by those from an advocacy
background (not clinicians), clinicians’ referrals were sent
to a One Stop Shop (not named advocates), with no elec-
tronic prompt embedded within the electronic medical
record, encouraging clinicians to ask about DVA when
clinically relevant. The comparator site was not chosen at
random. It was invited to participate in this research be-
cause it had declined to commission IRIS, but had
commissioned an alternative DVA education package.
Outcomes
Effectiveness outcomes
The primary outcome measure is the number of referrals
received by DVA service providers from general practices.
The denominator is the number of women aged 16 years
and above within the practice. This is an evidence-based,
intermediate outcome measure, on a causal pathway to-
wards decreased DVA, and possibly better mental health
and improved quality of life for women who are referred
to specialist DVA services [12].
The secondary outcome measure is the number of
women in whose medical records electronic DVA codes,
representing DVA identification are used. The denomin-
ator is the number of women aged 16 years and above reg-
istered within each practice. Other pre-specified secondary
outcome measures are the number of referrals received by
MARACs from general practice, the type of contact and
support offered to women by DVA advocates.
Process outcomes
Context for IRIS implementation, factors influencing
IRIS implementation, local adaptations of IRIS and the
reach of IRIS training is examined, at the northeast
London IRIS sites - A, B, C, D and F.
Qualitative outcomes
Theoretically informed analysis of the features contribut-
ing to sustainable implementation of IRIS is conducted
at sites B and G (see Appendix A).
Data sources, collection and management
Quantitative data
We use historic and prospective data routinely collected
from multiple sources:
1. DVA service providers: number of referrals received
by their DVA workers, from general practices, with
the date that each referral is received, the general
practice from which it is received, the type of contact
that is then made and the type of support required.
2. IRIS AEs: record data in referral spreadsheets, with
each referral received, the referral date, the practice
from which it is received, the contact type and
support type, including whether a referral is made
to a MARAC. They also record the dates of all IRIS
training delivery, the number of practice staff that
attend and who specifically delivers the training.
These paper based records, are electronically
entered on to spread sheets and shared with the
researchers either directly or via IRISi.
3. General practices’ electronic medical records (EMR)
for DVA codes used, each code with a date stamp
and the general practice, at which it was used. EMR
searches and data extraction are carried out
remotely using the EMIS (Egton Medical
Information Systems) web system located in the
Centre for Primary Care and Public Health, Queen
Mary, University of London.
4. Electronic searches conducted centrally extract the
number of women aged 16 years and above
registered at each general practice and the Index of
Multiple Deprivation score.
5. Online anonymous questionnaire survey,
incorporating an implementation measure based on
Normalisation Process Theory [29] and
administered via the Bristol Online Survey (BOS)
tool (https://www.onlinesurveys.ac.uk/).
6. A five-item checklist assesses the fidelity of IRIS,
identifying IRIS’ local adaptations.
 Is DVA training practice based?
 Is a local GP, the IRIS CL, delivering training
alongside the AE?
 Is the IRIS AE, based in a local DVA service?
 Is the IRIS AE delivering training & receiving
referrals?
 Is the electronic prompt & recording template,
been activated?
7. Practice websites for the total number of practice
staff employed. All contained a list of practice staff.
All extracted data are entered into the study database
for statistical analysis.
Qualitative data
Qualitative data are derived from the free text comments
generated by the online anonymous questionnaire survey
(see above), participant observation, document analysis
and interviews – semi-structured, using purposive sam-
ples of general practice staff (clinical and non-clinical),
AEs, local stakeholders, including commissioners and IRIS
service users. This work describes and understands ration-
ale for any features unique to a particular site, capturing
the views of professionals involved in implementing IRIS
and patients who have been referred into the IRIS service.
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Data analysis
Quantitative data analysis
Sample size The sample size was determined by simula-
tion, using the SimSam package in Stata [30]. Simulations
were of an analysis of monthly counts with a Poisson dis-
tribution. We assumed a typical practice had an average re-
ferral rate at baseline of 4.5 per 100,000 per month, based
on data from the IRIS cluster randomised trial [9], with this
rate varying between practices with a 95% normal range of
1.7 to 12.2 per 100,000 per month. We further assumed
there were 3000 eligible women per practice, and 180 prac-
tices. We determined the number of months of data re-
quired to detect a doubling of the referral rate following
the introduction of the intervention, with 90% power at
the 5% significance level, assuming that different practices
introduced the intervention at different times, uniformly
over this period. Simulation showed that 17 months of data
were required. In order to capture any seasonality in the
referral rates we increased this to 24 months.
We use an interrupted time series segmented regression
approach with a mixed effects Poisson regression model, to
examine the effect of the IRIS intervention on the primary
outcome measure (the number of referrals received by DVA
service providers from general practices); and the secondary
outcome measure (the number of first times that DVA
identification electronic codes are used in medical notes by
clinicians). We compare these outcome measures before
and after the date of the first IRIS training session, taken
from individual general practices (i.e. practice level data),
from multiple general practices. This date of the first IRIS
training session is taken as the date of IRIS implementation.
Figure 1 depicts an interrupted time series segmented
regression approach. Using this approach it is possible to
examine whether there is a change in level immediately
and/or a change in regression slope following the imple-
mentation of the intervention, i.e. a change in the gradient
of the slope pre- and post-intervention.
For each practice the outcomes are defined as a daily fre-
quency. The observations occurring on the day that the
training is received are excluded, as it is not possible to say
whether these occurred before or after training. Graphical
displays of the data show average daily rates (per 1000
people) plotted against time centered on IRIS implementa-
tion. A moving average smoothing function, with equal
weights, is applied to the data, with an unadjusted line of
best fit added, before and after the training.
The ITS model includes a random effect of practice and
fixed effects of training (pre or post in any given day in
any given practice), the slope of the underlying time trend,
the change in slope following the training, site (five
London boroughs), and month and day of the week to
allow for any seasonal effect of time. If for either outcome
measure there is evidence of over-dispersion of the daily
frequencies compared with a Poisson distribution then we
model this with a random effect of day nested within the
random effect of practice. We also adjust for the
log-transformed number of women aged 16 years and
above registered at that practice, every quarter, as an offset
variable in the analysis. This allows us to control for the
available population size at any one time. The analysis in-
cludes only those general practices that received IRIS
training. We exclude practices where 50% or more of the
list size data are missing, meaning we do not know the
number of women aged 16 years and above registered at
the practice. Regression coefficients are presented as inci-
dence rate ratios. Data is analysed using the Stata V14
package (StataCorp LP, College Station, TX).
Sub-group analyses
A priori additional analyses include comparing the dif-
ferent implementation sites (A, B, C & D) to each other
and the comparator site (E). The ITS analysis is run sep-
arately within each site. A forest plot is used to compare
these individual analyses. Deprivation scores are used to
check that deprivation does not confound the results.
Process evaluation data analysis
Survey data are exported from BOS to Stata V14 and
analysed using descriptive statistics (means, standard
deviations and frequencies) for the quantitative data.
Qualitative data analysis
Interview data are transcribed verbatim and coded the-
matically, using a mixture of inductive and deductive ap-
proaches. Theoretically informed analysis is conducted.
Significant patterns are identified and the data examined
for deviant cases.
Knowledge mobilisation
We propose to present the findings from this study to key
stakeholders at multiple local, national & international,
Fig. 1 An interrupted time series segmented regression approach
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non-academic and academic, conferences, meetings and
workshops. We will also report our findings in academic
and non-academic publications, sharing with national and
international health policy fora, including contributions to
the UK Government’s planned landmark Domestic Abuse
Bill. The final IRIS ITS analysis results, supported with
qualitative insights and web-based publicity will be pre-
sented to our local partners, including healthcare profes-
sionals, IRIS CLs, IRIS AEs, their managers and local third
sector DVA host agencies, as well as local health care
commissioners based in CCGs, Public Health, Local Au-
thorities and the Police & crime commissioners whilst
highlighting their role in integrating commissioning, using
strategic partnerships.
Discussion
This is the first interrupted time series analysis of an inter-
vention to improve the health care response to domestic
violence. The findings of this observational segmented
regression interrupted time series analysis of GP IRIS imple-
mentation, outside a trial setting will characterise its suit-
ability for national implementation in the United Kingdom.
It will inform decisions about the future commissioning of
IRIS in the UK. If the findings are positive, this will support
the more widespread commissioning of IRIS despite
the on-going constraints of austerity that are dispropor-
tionally reducing women’s services https://www.theguardia-
n.com/world/2017/mar/09/women-bearing-86-of-austerity
-burden-labour-research-reveals. Comparison of the imple-
mentation sites, using integrated quantitative and
qualitative findings may help us understand the core
components of IRIS that should be retained in the
programme when commissioned locally or nationally
so that the impact of IRIS is not diluted. If the find-
ings are not positive then careful thought is required
to consider what should be the next step, on what
has been a difficult path, on the rough terrain of im-
proving the healthcare response to DVA.
Endnote
1IRISi – for further information see http://www.irisdo-
mesticviolence.org.uk/iris/ & http://irisi.org
Appendix
Pre-specified case study inclusion criteria
The following inclusion criteria are used to determine
sites to be included as a case study:
 Sites not involved in the original IRIS trial
 Sites that had commissioned IRIS for more than
two years
 Sites that are not anomalous in their delivery of
IRIS - based on discussion with the IRIS
Implementation team
Additional file
Additional file 1: IRIS publicity materials supplied. (ZIP 1802 kb)
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